Tim D. Smith

Bangor, NIR LL571UT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 31 publications

Hypoxia and DNA-Repair Radiosensitivity Signatures Are Associated with Radiotherapy-Modified Survival in TCGA Breast Cancer, with External Prognostic Validation of the Hypoxia Score in METABRIC.

Hypoxia and DNA-Repair Radiosensitivity Signatures Are Associated with Radiotherapy-Modified Survival in TCGA Breast Cancer, with External Prognostic Validation of the Hypoxia Score in METABRIC.

Journal: Biotech (Basel (Switzerland))

Published: January 27, 2026

Gene Expression in Muscle-Invasive and Non-Muscle-Invasive Bladder Cancer Cells Exposed to Hypoxia.

Gene Expression in Muscle-Invasive and Non-Muscle-Invasive Bladder Cancer Cells Exposed to Hypoxia.

Journal: Cancers

Published: June 26, 2025

Cell Surface Proteomics Reveals Hypoxia-Regulated Pathways in Cervical and Bladder Cancer.

Cell Surface Proteomics Reveals Hypoxia-Regulated Pathways in Cervical and Bladder Cancer.

Journal: Proteomes

Published: May 30, 2025

An overview of the role of radionuclides in targeted cancer treatment: application of biomarkers for patient selection and developments to improve treatment efficacy.

An overview of the role of radionuclides in targeted cancer treatment: application of biomarkers for patient selection and developments to improve treatment efficacy.

Journal: Frontiers in oncology

Published: February 06, 2025

Immune effects of α and β radionuclides in metastatic prostate cancer.

Immune effects of α and β radionuclides in metastatic prostate cancer.

Journal: Nature reviews. Urology

Published: July 23, 2024

Gene Abnormalities and Modulated Gene Expression Associated with Radionuclide Treatment: Towards Predictive Biomarkers of Response.

Gene Abnormalities and Modulated Gene Expression Associated with Radionuclide Treatment: Towards Predictive Biomarkers of Response.

Journal: Genes

Published: May 01, 2024

CRISPR-Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer.

CRISPR-Cas9 potential for identifying novel therapeutic targets in muscle-invasive bladder cancer.

Journal: Nature reviews. Urology

Published: April 29, 2024

Implementation of Oxygen Enhanced Magnetic Resonance Imaging (OE-MRI) and a Pilot Genomic Study of Hypoxia in Bladder Cancer Xenografts.

Implementation of Oxygen Enhanced Magnetic Resonance Imaging (OE-MRI) and a Pilot Genomic Study of Hypoxia in Bladder Cancer Xenografts.

Journal: Cancer genomics & proteomics

Published: April 05, 2024

Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation Therapy.

Hypoxia-Associated Gene Signatures Are Not Prognostic in High-Risk Localized Prostate Cancers Undergoing Androgen Deprivation Therapy With Radiation Therapy.

Journal: International journal of radiation oncology, biology, physics

Published: March 12, 2024

A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trial.

A hypoxia biomarker does not predict benefit from giving chemotherapy with radiotherapy in the BC2001 randomised controlled trial.

Journal: EBioMedicine

Published: June 19, 2023

Comparison of multiple gene expression platforms for measuring a bladder cancer hypoxia signature.

Comparison of multiple gene expression platforms for measuring a bladder cancer hypoxia signature.

Journal: Molecular medicine reports

Published: March 24, 2022

Selection of endogenous control genes for normalising gene expression data derived from formalin-fixed paraffin-embedded tumour tissue.

Selection of endogenous control genes for normalising gene expression data derived from formalin-fixed paraffin-embedded tumour tissue.

Journal: Scientific reports

Published: June 16, 2020

Showing 1-12 of 31

Last Updated: 09/26/2026